| |
|
|
 |
| |
|
|
| |
|
| |
 |
The Supreme Court
of the United States landmark decision on the Affordable Care Act
creates one of the most significant points in the modern healthcare
timeline that stakeholders must now chart their future strategic course
from. The majority ruling upholds the Act, but allows for states to opt
out of Medicaid expansion without losing base levels of Medicaid
funding.
Furthermore, if there was any doubt, Medicare and Medicaid's push to
drive healthcare efficiency will continue, and health care providers
will need to continue to gear up their efforts to take risk on managing
the costs of certain diagnoses in response to bundling programs, value
based purchasing penalty programs and, for a few, the shared savings
program.
Implementation will certainly proceed "a pace" and those who are
interested in changing components of the ACA (e.g., the device tax) will
undoubtedly turn their attention toward getting their "fix" included in
omnibus legislation during the lame duck session or later addressing the
sequester, entitlements, and SGR among others.
It is vital for organizations going forward to have an understanding not
just the detailed aspects of the Decision, but also the strategic
implications of the Decision on the future direction of the delivery and
business of public and private healthcare in the United States, with
particular regard to the Medicaid issues. The options and timelines need
to be re-visited for stakeholders, who up to this point might have been
fence-sitting regarding Health Insurance Exchanges, while the Mandate
issue awaited the Supreme Court decision. Consideration needs to be
given to potential subsequent actions at the state levels that will
impact the ACT, along with subsequent regulatory guidance that had been
delayed, at least in part, by the pending decision, and of course, the
future legislation and the political arena.
In
order to chart their course forward for this decade, Stakeholders will
need to be fully equipped with the intelligence provided in this special HealthcareWebSummit briefing provided by nationally noted healthcare
legal and policy thought leader Mark Lutes from EpsteinBeckerGreen's
Washington DC office.
Please join EpsteinBeckerGreen's Mark E. Lutes on Thursday, July 19th, 2012 as he
provides a thorough review and analysis of the Supreme Court decision's
impact on the Affordable Care Act with particular regard to the Medicaid
issues, as well as the implications,
logistics, and strategic considerations for stakeholders as they move
forward in the post-SCOTUS ACA-with-Mandate environment, with time allotted for
attendee questions and answers.
|
 |
Participants will be able to:
- Understand the detailed components of the Supreme Court
Decision, including the Mandate and Medicaid provisions.
- Consider the impact and implications of the Decision upon
applicable provisions of the Affordable Care Act, with
particular emphasis on state opt-out or inclusion in Medicaid
expansion.
- Examine the timeline and logistics involved for stakeholders
going forward, based upon the Decision's impact, including
Health Insurance Exchanges and Medicaid expansion.
- Explore the strategic considerations for stakeholders in the
aftermath of the Decision, including potential relevant
subsequent events such as state-level actions and regulatory
guidance.
- Engage in interactive learning through online question
submission, attendee feedback and opportunity for follow up
questions, and networking with attendees, faculty and other
professionals through dedicated LinkedIn group.
|
 |
|
Interested attendees would include:
- C-Suite Executives
- Legal and Regulatory Executives and Staff
-
Strategy, Planning and
Policy Executives and Staff
- Health Reform Implementation Executives and Staff
- Medical Directors
- Business Intelligence Staff
- Communications Executives and Staff
- Other Interested Parties
Attendees would represent
organizations including:
-
Health Plans
-
Hospitals and Health Systems
- Provider Networks and Accountable Care Organizations
- Employers
- Third Party Administrators
-
Pharmaceutical Organizations
- PBMs
- Other Healthcare Providers
- Benefit Consulting Organizations
- Solutions Providers
- State and Local Government Agencies
- Associations, Institutes and Research Organizations
- Media
- Other Interested Organizations
|
| |
 |
|
| |
| |
Individual Registration Fee: $195. Audio Conference CD-ROM: $40
for attendees; $285 for non-attendees after the event.
|
|
| |
|
|
| |
|
|
|
| |
 |
|
|
|
Mark E. Lutes is a Member of the Firm in the Health Care and
Life Sciences Practice and serves on the firm's Board of
Directors. He has practiced with the firm for 26 years.
Prior to that he was a legislative adviser to the Federal
Trade Commission. He also offers strategic counsel in health
policy and on reimbursement strategy through the firm's
affiliates EBG Advisors, Inc. and National Health Advisors,
LLC.
Mr. Lutes is a leader in the firm's representation of
private equity and financial services firms with health care
companies in their portfolios. He routinely deploys
multidisciplinary teams of attorneys, reimbursement
specialists, engineers and scientists, to assess the
reimbursement, FDA and other domestic and international
regulatory approvals, fraud and abuse compliance, CMS and
legislative landscapes and other issues impacting proposed
client investments in health care companies. Mr. Lutes
combines experience with the corporate aspects of
transactions with his deep experience in health care
compliance issues to provide clients with practical advice
in the negotiation of warranty and indemnification issues
and in assessing risk factors in health and life science
deals. He has advised on the largest transactions in the
health care market including services, pharmaceutical and
device companies.
Mr. Lutes is also an experienced antitrust counselor to
health care companies contemplating mergers or acquisitions
and has facilitated the antitrust clearance of numerous
significant hospital mergers. He has managed the defense of
high profile healthcare antitrust actions by the FTC.
Mr. Lutes has a deep understanding of managed care markets
and regulation. He is consulted by a variety of providers
and payors in structuring innovative payment arrangements.
Additionally, he counsels on hospital and physician ventures
and compliance issues and in the area of information privacy
and security. Mr. Lutes has developed privacy and security
audit tools which support client compliance needs.
He has been honored as a Washington DC "Super Lawyer" and by
Nightingales as a leading health care antitrust lawyer. He
is Chambers rated. Mr. Lutes is active in his parish and
serves as Chair of the Advisory Board of the Spanish
Catholic Center, a social and health services nonprofit. He
is a recipient of the Caritas Award from Catholic Charities
of the Archdiocese of Washington, DC. Mr. Lutes also has
over a decade of service in leadership in the Boy Scouts of
America organization.
|
|
|
|
|
|
 |
 |
|
- 1101 Standiford Ave. Suite C-3 Modesto, CA 95350
Phone 209.577.4888 |
e-Mail
infohws@healthwebsummit.com
| Fax
209.577.3557
- copyright
, MCOL All rights reserved. Terms
of Use apply to this site and participation in events.
|
|
| |